Skip to main content
SpringerLink
Log in

Markers and Immunoprofile of Miscellaneous Tumors and Tumors of Uncertain Differentiation

  • Chapter
  • First Online:
Immunohistochemistry in Tumor Diagnostics

  • 2766 Accesses

Abstract

Vimentin, pan-cytokeratin, actin, desmin, HMB45, S100, CD34, CD99, TLE-1.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kosemehmetoglu K, Vrana JA, Folpe AF. TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft and bone neoplasms. Mod Pathol. 2009;22:872–8.

    Article  CAS  PubMed  Google Scholar 

  2. Ch Foo W, Cruise MW, Wick MR, Hornick JL. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol. 2011;135:839–44.

    Article  Google Scholar 

  3. Valente A, Tull J, Zhang S. Specificity of TLE1 expression in unclassified high-grade sarcomas for the diagnosis of synovial sarcoma. Appl Immunohistochem Mol Morphol. 2013;21(5):408–13.

    Google Scholar 

  4. Matsuyama A, Hisaoka M, Iwasaki M, et al. TLE1 expression in malignant mesothelioma. Virchows Arch. 2010;457(5):577–83.

    Article  CAS  PubMed  Google Scholar 

  5. Argani P, Lal P, Hutchinson B, et al. Aberrant immunoreactivity for TFE3 in neoplasms with TFE3 gene fusion. A sensitive and specific immunohistochemical assay. Am J Surg Pathol. 2003;27(6):750–61.

    Article  PubMed  Google Scholar 

  6. Lauer SR, Edgar MA, Gardner JM, et al. Soft tissue chordomas: a clinicopathologic analysis of 11 cases. Am J Surg Pathol. 2013;37:719–26.

    Article  PubMed  Google Scholar 

  7. Miettinen M, Wang Z, Lasota J, et al. Nuclear Brachyury expression is consistent in chordoma, common in germ cell tumors and small cell carcinomas, and rare in other carcinomas and sarcomas. An immunohistochemical study of 5229 cases. Am J Surg Pathol. 2015;39:1305–12.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carl-Thiem-Klinikum, Institut für Pathologie, Cottbus, Germany

    Muin S. A. Tuffaha

  2. Vivantes Klinikum Neukölln, Institut für Pathologie, Berlin, Germany

    Hans Guski

  3. Universität Bonn, UKB, Institut für Pathologie, Bonn, Germany

    Glen Kristiansen

Authors
  1. Muin S. A. Tuffaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Guski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glen Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Miscellaneous Tumors and Tumors of Uncertain Differentiation. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation